Concord Medical Services Holdings Limited Overview
Pro stress-test →Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China, with involvement in leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company serves as a comprehensive healthcare solutions provider focused on cancer treatment infrastructure and medical device distribution.
Strategic Profile
Pro stress-test →The company operates through two segments: network and hospital, with its network including radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services. As of (May 2026), the company faces significant valuation pressure with a market cap of $16.98M, reflecting challenges in execution or market sentiment.
Competitive Landscape
Pro stress-test →Concord Medical operates in China's oncology treatment and diagnostic imaging sector, competing with hospital networks, private cancer centers, and radiation therapy providers. The company differentiates through integrated service provision combining equipment leasing, hospital management, and premium treatment services. Competition includes both state-owned hospital systems and emerging private healthcare providers in China's cancer care market.
Industry Context
Concord Medical Services Holdings Limited operates in Oncology Services and Diagnostic Imaging.
Key facts
Founded: 1997 · Headquarters: Beijing, China · Employees: N/A · Revenue: N/A · Market cap: $16.98M (as of May 1, 2026)